CochLear (OTCMKTS:CHEOY) Shares Gap Up – Here’s Why

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY)’s stock price gapped up prior to trading on Tuesday. The stock had previously closed at $45.44, but opened at $48.60. CochLear shares last traded at $48.60, with a volume of 438 shares changing hands.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on CHEOY. Jefferies Financial Group lowered CochLear from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, July 22nd. Canaccord Genuity Group downgraded CochLear from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 18th. Finally, Royal Bank Of Canada lowered CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price target for the company. in a research note on Thursday, July 16th. Five research analysts have rated the stock with a Hold rating. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $117.00.

CochLear Price Performance

The stock’s fifty day moving average is $47.88 and its 200-day moving average is $44.00.

CochLear Company Profile

Cochlear Limited is an Australian medical device company that develops, manufactures and supplies implantable hearing solutions for people with moderate to profound hearing loss. Its portfolio includes cochlear implants, bone conduction implants and related sound processors, accessories and connectivity products designed to help users hear in a range of environments.

The company also provides clinical support, rehabilitation resources, software, technical services and ongoing care for recipients, clinicians and hearing professionals.